For the Inventor, By the Inventor

Enter assignee name

Tampa, FL, United States of America

Intezyne Technologies, Incorporated

USPTO Granted Patents = 37

% Expired Patents = 21.6

CIPO Patents = 2

EPO Patents = 5

Trademarks = 1

Forward Citations = 276

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Kevin N Sill (35 out of 48 patents)

Habib Skaff (23 out of 28 patents)

Kurt Breitenkamp (19 out of 26 patents)

4. Rebecca Breitenkamp (7 out of 7 patents)

5. Adam Carie (5 out of 10 patents)

6. David L Morse (4 out of 19 patents)

7. Josef Vagner (4 out of 14 patents)

8. Narges Tafreshi (4 out of 7 patents)

9. Jonathan L Sessler (4 out of 89 patents)

10. Natalie M Barkey (4 out of 4 patents)

11. Christian Preihs (4 out of 6 patents)

12. Victor J Hruby (4 out of 39 patents)

13. Tomas Vojkovsky (4 out of 11 patents)

14. Robert J Gillies (4 out of 25 patents)

15. Janni Mirosevich (3 out of 3 patents)

37 patents: Sort by Forward Citations

1. 12173087 - Melanocortin 1 receptor ligands and methods of use (2024-12-24),

2. 11230568 - Melanocortin 1 receptor ligands and methods of use (2022-01-25),

3. 10857147 - SN-38 loaded iron crosslinked micelle and methods thereof (2020-12-08),

4. 10329326 - Melanocortin 1 receptor ligands and methods of use (2019-06-25),

5. 10047197 - Block copolymers for stable micelles (2018-08-14),

6. 9944754 - Block copolymers for stable micelles (2018-04-17),

7. 9944752 - Block copolymers for stable micelles (2018-04-17),

8. 9499665 - Block copolymers for stable micelles (2016-11-22),

9. 9441013 - Melanocortin 1 receptor ligands and methods of use (2016-09-13),

10. 9089578 - Method of treating neuroendocrine tumors (2015-07-28),

11. 9078930 - Block copolymers for stable micelles (2015-07-14),

12. 8980326 - Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents (2015-03-17),

13. 8921111 - Polymer based polynucleotide transfection agents (2014-12-30),

14. 8779008 - Polymeric micelles for drug delivery (2014-07-15),

15. 8747904 - Polymeric micelles for polynucleotide encapsulation (2014-06-10),

Intezyne Technologies, Incorporated is a biopharmaceutical company focused on developing therapeutic products for the treatment of various cancers. With a dedication to advancing cancer care, Intezyne employs an innovative approach combining proprietary nanotechnology with targeted drug delivery systems. By leveraging cutting-edge science, Intezyne aims to improve patient outcomes and quality of life. For more information about Intezyne and its ongoing research, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Intezyne Technologies, Incorporated

37 Patents

#18 in Tampa, FL

#215 in Florida

#9,231 in US

#18,212 in the World

Tampa, FL, United States of America

Intezyne Technologies, Incorporated

Forward Citations = 276

21 inventors:

Kevin N Sill (35 out of 48 patents)

Habib Skaff (23 out of 28 patents)

Kurt Breitenkamp (19 out of 26 patents)

4. Rebecca Breitenkamp (7 out of 7 patents)

5. Adam Carie (5 out of 10 patents)

Please report any incorrect information to [email protected]

Loading…